Polymorphic ventricular tachycardia is an abnormal heart rhythm where the bottom chambers of your heart beat too quickly. People with severe cases may experience sudden cardiac arrest. Conditions that ...

Pulseless ventricular tachycardia occurs when an abnormally rapid heart rate originating in the heart’s lower chambers makes a pulse undetectable. Emergency cardiac defibrillation is usually necessary ...

Non-sustained ventricular tachycardia is an abnormally fast heart rate that occurs in the lower chambers of the heart and lasts for less than 30 seconds. Tachycardia is a heart rate that is faster ...

Ventricular tachycardia is when the lower chamber of the heart beats too fast to pump efficiently. A common heart rate with ...

Ventricular tachycardia (VT) is a heart condition that begins in the lower chambers of the heart. It causes the heart to beat very quickly at a rate of over 100 beats per minute. Symptoms of VT ...

Arrhythmogenic right ventricular dysplasia/cardiomyopathy was first reported as the partial replacement of the right ventricular myocardium by fat or fibrous tissue. In 1965, researchers described the ...

Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...

A new multicenter trial has used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide. A first ...

A single noninvasive radiation therapy treatment safely reduced the burden of ventricular tachycardia, with effects persisting for 2 years in most patients, according to data from the ENCORE-VT trial ...

Solid Biosciences announces Phase 1b trial for SGT-501, a gene therapy for catecholaminergic polymorphic ventricular tachycardia, with FDA designations. Solid Biosciences Inc. has announced the ...